Lipocine Inc.
Lipocine Inc. scores highest on Torque (58) and lowest on Nitro (14). Its PosiPenta is 40.87 out of 100, around the middle of similar companies.
On the Penta Grid this week, Lipocine Inc. is Grid #509 of 837 in the Healthcare sector in United States, and Grid #2,801 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Lipocine Inc. | 40.87 | 44 | 39 | 14 | 58 | 49 |
| Karyopharm Therapeutics Inc. | 36.57 | 0 | 38 | 10 | 95 | 39 |
| Sintx Technologies, Inc. | 35.31 | 23 | 42 | 37 | 19 | 55 |
| Actuate Therapeutics, Inc. Common stock | 39.84 | 5 | 45 | 16 | 88 | 45 |
| AEON Biopharma, Inc. | 44.09 | 0 | 46 | 22 | 95 | 57 |
| Biofrontera Inc. | 42.22 | 28 | 77 | 49 | 9 | 48 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -0.84 |
| P/B ratio | 0.59 |
EEarnings
| Trailing EPS | ₹-175.22 |
| Forward EPS | ₹-117.45 |
NNitro
| Price | 147.76 |
| 52-week high | 1171.62 |
| 52-week low | 140.18 |
| Fall from 52-week high | 87.4% |
TTorque
| Return on equity (ROE) | -60.94% |
| Debt-to-equity | 0.01 |
AAnchor
| Beta (price swings) | 0.40 |
| Market cap | ₹121 Cr |
| Insider holding | 4.96% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Lipocine Inc.'s PosiPenta score?
Lipocine Inc.'s PosiPenta is 40.87 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Lipocine Inc. stand on the Penta Grid?
On the Penta Grid this week, Lipocine Inc. is Grid #509 of 837 in the Healthcare sector in United States, and Grid #2,801 of 4,000 in United States.
Which PosiPenta pillar is strongest for Lipocine Inc.?
Torque (durability), with a score of 58 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Lipocine Inc.?
Nitro (momentum), with a score of 14 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.